Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

209.82
+0.76500.37%
Volume:485.79K
Turnover:101.73M
Market Cap:10.56B
PE:33.24
High:210.55
Open:208.74
Low:208.47
Close:209.05
52wk High:217.12
52wk Low:138.79
Shares:50.35M
Float Shares:50.35M
Volume Ratio:0.94
T/O Rate:0.96%
Dividend:0.42
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.30
PE(LYR):-140.44

Loading ...

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 25

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Reuters
·
Aug 25

Sector Update: Healthcare

MT Newswires Live
·
Aug 25

Exchange-Traded Funds Fall, US Equities Mixed After Midday

MT Newswires Live
·
Aug 25

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

TIPRANKS
·
Aug 25

European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading

MT Newswires Live
·
Aug 24

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

TIPRANKS
·
Aug 24

Political and General News Events from August 24

Reuters
·
Aug 24

Exchange-Traded Funds, Equity Futures Fall Pre-Bell Monday as Investors Await Details on US Sanctions Against Iran

MT Newswires Live
·
Aug 24

Morning Movers: Regenxbio sinks following clinical hold on RGX-121

TIPRANKS
·
Aug 24

Sector Update: Healthcare

MT Newswires Live
·
Aug 24

Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy

GlobeNewswire
·
Aug 24

Regenxbio reports FDA placed clinical hold on RGX-121

TIPRANKS
·
Aug 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Aug 24

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX)

TIPRANKS
·
Aug 24

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Reuters
·
Aug 24

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.
·
Aug 24

ETF Weekly | ETHU Jumps 62%; NUGT Climbs 29%; SMST, MSTZ Sink 45%; Crypto Leverage Sets the Pace

ETF Weekly
·
Aug 23